DK113854B - Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf. - Google Patents

Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf.

Info

Publication number
DK113854B
DK113854B DK304861AA DK304861A DK113854B DK 113854 B DK113854 B DK 113854B DK 304861A A DK304861A A DK 304861AA DK 304861 A DK304861 A DK 304861A DK 113854 B DK113854 B DK 113854B
Authority
DK
Denmark
Prior art keywords
aminoacytylenes
preparation
acid addition
addition salts
salts
Prior art date
Application number
DK304861AA
Other languages
English (en)
Inventor
K Campbell
R Majewski
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Publication of DK113854B publication Critical patent/DK113854B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
DK304861AA 1960-07-26 1961-07-25 Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf. DK113854B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4529260A 1960-07-26 1960-07-26
US118261A US3176019A (en) 1960-07-26 1961-06-20 Substituted aminobutynyl acetates

Publications (1)

Publication Number Publication Date
DK113854B true DK113854B (da) 1969-05-05

Family

ID=26722613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK304861AA DK113854B (da) 1960-07-26 1961-07-25 Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf.

Country Status (9)

Country Link
US (1) US3176019A (da)
BE (1) BE606560A (da)
CH (1) CH421078A (da)
DE (1) DE1216866B (da)
DK (1) DK113854B (da)
ES (1) ES269353A1 (da)
FR (1) FR1325M (da)
GB (1) GB940540A (da)
NL (2) NL124473C (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736577A (en) * 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US3864388A (en) * 1970-12-29 1975-02-04 Sumitomo Chemical Co Alkynyl esters of {60 -alkoxy-{60 -phenyl alkenoic acid
US5036107A (en) * 1986-06-27 1991-07-30 Marion Merrell Dow Inc. 1,7-substituted heptyn-2-ones and use
US4957941A (en) * 1987-11-16 1990-09-18 United Pharmaceuticals, Inc. Anti-spasmdoic agents having an acetylenic bond
IL91377A (en) * 1988-09-14 1996-09-12 Nippon Shinyaku Co Ltd Derivatives of botinylamine glycolate
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
AU3799997A (en) * 1996-07-09 1998-02-02 Sepracor, Inc. Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity
US5973182A (en) * 1998-10-22 1999-10-26 Sepracor Inc. Carbonate Intermediates useful in the preparation of optically active cyclohexylphenylglycolate esters
US6140529A (en) * 1998-10-22 2000-10-31 Sepracor Inc. Synthesis of optically active cyclohexylphenylglycolate esters
WO2001080796A1 (en) * 2000-04-26 2001-11-01 Watson Pharmaceuticals, Inc. Minimizing adverse experience associated with oxybutynin therapy
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
WO2003035599A1 (en) 2001-10-26 2003-05-01 Pharmacia & Upjohn Company Quarternary ammonium compounds and their use as antimuscarinic agents
AU2002345266B2 (en) 2002-07-08 2009-07-02 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
EP1546098B1 (en) * 2002-07-31 2008-05-28 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
EP1545508A4 (en) * 2002-08-09 2009-11-25 Ranbaxy Lab Ltd 3,6-DISUBSTITUTED AZABICYCLO ¬3.1.0 HEXANE DERIVATIVES AS USEFUL AS MUSCARINIC RECEPTOR AGONISTS
EP1534675B1 (en) * 2002-08-23 2009-02-25 Ranbaxy Laboratories, Ltd. Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
TW200412945A (en) 2002-10-25 2004-08-01 Upjohn Co Quaternary ammonium compounds
EP2177511A2 (en) 2002-12-10 2010-04-21 Ranbaxy Laboratories Limited Process for preparing 3,6-disubstituted azabicyclo derivatives
EP1583741A1 (en) * 2002-12-23 2005-10-12 Ranbaxy Laboratories, Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
DE60225195T2 (de) * 2002-12-23 2009-02-26 Ranbaxy Laboratories, Ltd. Flavaxat-derivate als muscarin-rezeptor antagonisten
US7488748B2 (en) 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
US7517905B2 (en) * 2003-04-09 2009-04-14 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
US7592359B2 (en) * 2003-04-10 2009-09-22 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EP1615887A1 (en) 2003-04-10 2006-01-18 Ranbaxy Laboratories, Ltd. Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
BRPI0409302A (pt) * 2003-04-11 2006-04-11 Ranbaxy Lab Ltd derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos
WO2006005980A1 (en) * 2004-06-16 2006-01-19 Ranbaxy Laboratories Limited Xanthine derivatives useful as muscarinic receptor antagonists
WO2006018708A2 (en) * 2004-08-19 2006-02-23 Ranbaxy Laboratories Limited Pyrrolidine derivatives as muscarinic receptor antagonists
US20080280883A1 (en) * 2004-09-24 2008-11-13 Mohammad Salman Muscarinic Receptor Antagonists
US20090105221A1 (en) * 2004-09-29 2009-04-23 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
US20100016400A1 (en) * 2004-11-19 2010-01-21 Naresh Kumar Azabicyclic muscarinic receptor antagonists
US20100035954A1 (en) * 2004-12-15 2010-02-11 Mohammad Salman Acid addition salts of muscarinic receptor antagonists
US20080319043A1 (en) * 2005-05-03 2008-12-25 Mohammad Salman 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
US20090010923A1 (en) * 2007-04-24 2009-01-08 University Of Maryland, Baltimore Treatment of cancer with anti-muscarinic receptor agents
WO2009122429A2 (en) * 2008-02-04 2009-10-08 Matrix Laboratories Limited Crystalline oxybutynin and process for preparing the same
AU2011245499B2 (en) 2010-04-30 2014-09-25 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
AU2011285928B9 (en) 2010-08-03 2018-08-02 B3Ar Therapeutics, Inc. Combinations of beta - 3 adrenergic receptor agonists and muscarinic receptor antagonists for treating overactive bladder
TW201338772A (zh) 2012-02-09 2013-10-01 Altherx Inc 藥學組合物
KR20170086659A (ko) 2014-12-03 2017-07-26 벨리셉트 테라퓨틱스, 인크. 하부 요로 증상을 위한 변형 방출형 솔라베그론을 이용한 조성물 및 방법
IL310527A (en) 2015-10-23 2024-03-01 B3Ar Therapeutics Inc Zwitterion solvegron and its uses
MX2020008086A (es) 2018-01-30 2021-02-15 Apnimed Inc Delaware Metodos y composiciones para tratar la apnea del sue?o.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE895595C (de) * 1943-09-29 1953-11-05 Basf Ag Verfahren zur Herstellung von Aminoalkinolen
DE1003209B (de) * 1953-03-24 1957-02-28 Basf Ag Verfahren zur Herstellung spasmolytisch wirksamer basischer Carbinole
US2867619A (en) * 1956-11-05 1959-01-06 Lakeside Lab Inc Aminoalkynyl-n-alkylpiperidine carboxylates
DE1083254B (de) * 1957-04-01 1960-06-15 Lakeside Lab In Verfahren zur Herstellung von blutdrucksenkenden N-disubstituierten Diaminoalkinen, deren Saeureadditionssalzen oder quaternaeren Ammoniumsalzen
DE1100617B (de) * 1959-10-22 1961-03-02 Basf Ag Verfahren zur Herstellung von 1-Dialkylamino-4-hydroxy-acetylenen-(2)

Also Published As

Publication number Publication date
GB940540A (en) 1963-10-30
BE606560A (fr) 1962-01-26
US3176019A (en) 1965-03-30
ES269353A1 (es) 1961-11-16
NL267508A (da)
NL124473C (da)
DE1216866B (de) 1966-05-18
FR1325M (fr) 1962-05-21
CH421078A (de) 1966-09-30

Similar Documents

Publication Publication Date Title
DK113854B (da) Fremgangsmåde til fremstilling af aminoacytylener, eller syreadditionssalte heraf.
DK107029C (da) Fremgangsmåde til fremstilling af substituerede 2-arylamino-1,3-diazacycloalkener eller syreadditionssalte deraf.
DK107167C (da) Fremgangsmåde til fremstilling af benzimidazolforbindelser eller syreadditionssalte deraf.
DK115999B (da) Fremgangsmåde til fremstilling af 9,10-dihydro-ergovalin eller syreadditionssalte heraf.
DK128814B (da) Fremgangsmåde til fremstilling af benzimidazolforbindelser eller syreadditionssalte deraf.
DK109037C (da) Fremgangsmåde til fremstilling af 2-alkyl-3-hydroxy-4,5-di-hydroxymethyl-pyridiner eller syreadditionssalte deraf.
DK111564B (da) Fremgangsmåde til fremstilling af sympathicolytisk virksomme phenoxyalkylguanidiner eller syreadditionssalte heraf.
DK104460C (da) Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf.
DK114559B (da) Fremgangsmåde til fremstilling af hydroxydiaminer eller syreadditionssalte deraf.
DK103672C (da) Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf.
DK110091C (da) Fremgangsmåde til fremstilling af substituerede diphenylalkylaminer eller syreadditionssalte heraf.
DK102807C (da) Fremgangsmåde til fremstilling af substituerede diphenylalkenylaminer eller syreadditionssalte heraf.
DK118189B (da) Analogifremgangsmåde til fremstilling af benzyloxyaminer eller syreadditionssalte heraf.
DK96113C (da) Fremgangsmåde til fremstilling af o-benzylphenoxy-β-1-piperidinopropan eller syreadditionssalte deraf.
DK101739C (da) Fremgangsmåde til fremstilling af 11a-halogentetracyclin-6,12-hemiketaler eller syreadditionssalte heraf.
DK101240C (da) Fremgangsmåde til fremstilling af 1,1-dicyclohexyl-2-(2-piperidyl-ethylen eller syreadditionssalte heraf.
DK105405C (da) Fremgangsmåde til fremstilling af 5-aryl-2-amino-2-oxazolin-4-oner eller syreadditionssalte heraf.
DK97884C (da) Fremgangsmåde til fremstilling af 1-trialkoxybenzyl-piperazin eller syreadditionssalte deraf.
DK102796C (da) Fremgangsmåde til fremstilling af 6-desoxy-6-demethyl-6-methylen-11a-halogentetracycliner eller syreadditionssalte heraf.
DK101689C (da) Fremgangsmåde til fremstilling af aminopropylacridaner eller syreadditionssalte deraf.
DK98126C (da) Fremgangsmåde til fremstilling af 2-guanidin-3,4-dihydroquinazolinforbindelser eller syreadditionssalte deraf.
DK96175C (da) Fremgangsmåde til fremstilling af 9,10-dihyfroantracenderivater eller syreadditionssalte heraf.
DK109748C (da) Fremgangsmåde til fremstilling af emetinforbindelser eller syreadditionssalte deraf.
DK96742C (da) Fremgangsmåde til fremstilling af homothioxanthen-derivater eller syreadditionssalte heraf.
DK97883C (da) Fremgangsmåde til fremstilling af 4-aza-thioxanthenderivater eller syreadditionssalte deraf.